Product NDC: | 54859-701 |
Proprietary Name: | Urin |
Non Proprietary Name: | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Active Ingredient(s): | .12; 81.6; 10.8; 36.2; 40.8 mg/1; mg/1; mg/1; mg/1; mg/1 & nbsp; Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54859-701 |
Labeler Name: | Llorens Pharmaceutical International Division |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 19990501 |
Package NDC: | 54859-701-04 |
Package Description: | 4 TABLET in 1 BOTTLE (54859-701-04) |
NDC Code | 54859-701-04 |
Proprietary Name | Urin |
Package Description | 4 TABLET in 1 BOTTLE (54859-701-04) |
Product NDC | 54859-701 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19990501 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Llorens Pharmaceutical International Division |
Substance Name | HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Strength Number | .12; 81.6; 10.8; 36.2; 40.8 |
Strength Unit | mg/1; mg/1; mg/1; mg/1; mg/1 |
Pharmaceutical Classes |